Study S002198

An Open-label,Sequential,Single-site Study to Evaluate the Pharmacokinetics of Warfarin When Coadministered With Polyethylene Glycol Loxenatide (PEX168) in Healthy Adult Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02461914
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 16
Start: 2015-08-01
Primary completion: 2015-12-12
Lead sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions: Healthy
Interventions: DRUG:PEX168; DRUG:Warfarin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Composite measure the plasma concentrations of warfarin [Baseline to Day51]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.